Ted Skolarus to Aged, 80 and over
This is a "connection" page, showing publications Ted Skolarus has written about Aged, 80 and over.
Connection Strength
1.147
-
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
Score: 0.110
-
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105.
Score: 0.083
-
Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017 04 18; 18(1):181.
Score: 0.067
-
Variation in readmission expenditures after high-risk surgery. J Surg Res. 2017 06 01; 213:60-68.
Score: 0.066
-
Understanding hospital readmission intensity after radical cystectomy. J Urol. 2015 May; 193(5):1500-6.
Score: 0.057
-
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer. 2014 May 01; 120(9):1409-16.
Score: 0.054
-
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011 Dec; 78(6):1345-9.
Score: 0.046
-
Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality. Cancer. 2012 Jun 01; 118(11):2837-45.
Score: 0.046
-
Primary care perspectives on prostate cancer survivorship: implications for improving quality of care. Urol Oncol. 2013 Aug; 31(6):727-32.
Score: 0.045
-
The delivery of prostate cancer care in the United States: implications for delivery system reform. J Urol. 2010 Dec; 184(6):2279-84.
Score: 0.043
-
The economic burden of prostate cancer survivorship care. J Urol. 2010 Aug; 184(2):532-8.
Score: 0.042
-
Regional differences in early stage bladder cancer care and outcomes. Urology. 2010 Aug; 76(2):391-6.
Score: 0.041
-
Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol. 2010 Feb; 183(2):455-8.
Score: 0.040
-
The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol. 2008 Feb; 179(2):439-43; discussion 443-4.
Score: 0.035
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
Score: 0.027
-
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
Score: 0.021
-
Resurrecting immortal-time bias in the study of readmissions. Health Serv Res. 2020 04; 55(2):273-276.
Score: 0.020
-
Implications of Cystectomy Travel Distance for Hospital Readmission and Survival. Clin Genitourin Cancer. 2019 12; 17(6):e1171-e1180.
Score: 0.020
-
Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469.
Score: 0.019
-
Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
Score: 0.019
-
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
Score: 0.018
-
Predictors and Cost of Readmission in Total Knee Arthroplasty. J Arthroplasty. 2018 09; 33(9):2759-2763.
Score: 0.018
-
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Urology. 2018 06; 116:68-75.
Score: 0.018
-
Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg. 2018 03 01; 153(3):243-250.
Score: 0.018
-
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer. 2018 02 01; 124(3):563-570.
Score: 0.017
-
Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population. Urology. 2017 04; 102:92-99.
Score: 0.016
-
Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60.
Score: 0.016
-
Veterans Affairs Telemedicine: Bringing Urologic Care to Remote Clinics. Urology. 2015 Aug; 86(2):255-60.
Score: 0.015
-
Reducing PSA-Based Prostate Cancer Screening in Men Aged?75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med. 2015 Aug; 30(8):1133-9.
Score: 0.014
-
Validating electronic cancer quality measures at Veterans Health Administration. Am J Manag Care. 2014; 20(12):1041-7.
Score: 0.013
-
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95.
Score: 0.013
-
Comparative effectiveness of external-beam radiation approaches for prostate cancer. Eur Urol. 2014 Jan; 65(1):162-8.
Score: 0.012
-
Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood). 2012 Apr; 31(4):750-9.
Score: 0.012
-
Identifying better practices for early-stage bladder cancer. Med Care. 2011 Dec; 49(12):1112-7.
Score: 0.012
-
Understanding prostate cancer spending growth among Medicare beneficiaries. Urology. 2011 Feb; 77(2):326-31.
Score: 0.011
-
Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology. 2011 Feb; 77(2):385-90.
Score: 0.011
-
Delays in diagnosis and bladder cancer mortality. Cancer. 2010 Nov 15; 116(22):5235-42.
Score: 0.011